RegenLab Files for IPO

Dow Jones

Sep 26

RegenLab filed for an initial public offering.

The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA.

RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clinical teams in New Jersey, Paris and Monthey, Switzerland.

It maintains full control of the development and industrialization cycle.

The company has numerous products across different stages of regulatory approval in both the E.U. and U.S. That includes products in musculoskeletal regeneration, advanced wound care, medical aesthetics and dermatology, and women's health and urogynecology.

RegenLab didn't disclose the pricing or amount of shares it plans to offer.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2670542230"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2670542230\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2670542230?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-26 04:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2670542230","market":"sg","top_or_hot":-1,"title":"RegenLab Files for IPO","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  RegenLab filed for an initial public offering. \n</p>\n<p>\n  The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA. \n</p>\n<p>\n  RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clinical teams in <a href=\"https://laohu8.com/S/NJR\">New Jersey</a>, Paris and Monthey, Switzerland. \n</p>\n<p>\n  It maintains full control of the development and industrialization cycle. \n</p>\n<p>\n  The company has numerous products across different stages of regulatory approval in both the E.U. and U.S. That includes products in musculoskeletal regeneration, advanced wound care, medical aesthetics and dermatology, and women's health and urogynecology. \n</p>\n<p>\n  RegenLab didn't disclose the pricing or amount of shares it plans to offer. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RegenLab Files for IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegenLab Files for IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-09-26 04:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  RegenLab filed for an initial public offering. \n</p>\n<p>\n  The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA. \n</p>\n<p>\n  RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clinical teams in <a href=\"https://laohu8.com/S/NJR\">New Jersey</a>, Paris and Monthey, Switzerland. \n</p>\n<p>\n  It maintains full control of the development and industrialization cycle. \n</p>\n<p>\n  The company has numerous products across different stages of regulatory approval in both the E.U. and U.S. That includes products in musculoskeletal regeneration, advanced wound care, medical aesthetics and dermatology, and women's health and urogynecology. \n</p>\n<p>\n  RegenLab didn't disclose the pricing or amount of shares it plans to offer. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2670542230","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2670542230","pubTimestamp":1790369880,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"RegenLab filed for an initial public offering.The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA.RegenLab was founded in Switzerland and is now U.S.-based. It oper","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4127":"投资银行业与经纪业","IPOS":"Renaissance International IPO ETF","KCE":"SPDR KBW Capital Markets ETF","FRHC":"Euronext CAC Health Care","REDS":"RPM Republican Senate ETF"},"translate_title":"RegenLab申请IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPOS":1.5,"FRHC":1.5,"REDS":1.5,"KCE":1.5},"content_text":"RegenLab filed for an initial public offering. \n\n\n  The regenerative medicine company plans to trade shares on Nasdaq under the ticker RGNA. \n\n\n  RegenLab was founded in Switzerland and is now U.S.-based. It operates three manufacturing sites and dedicated research and development and clinical teams in New Jersey, Paris and Monthey, Switzerland. \n\n\n  It maintains full control of the development and industrialization cycle. \n\n\n  The company has numerous products across different stages of regulatory approval in both the E.U. and U.S. That includes products in musculoskeletal regeneration, advanced wound care, medical aesthetics and dermatology, and women's health and urogynecology. \n\n\n  RegenLab didn't disclose the pricing or amount of shares it plans to offer.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}